These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Antenatal screening for Down's syndrome: where are we and where next? Haddow JE Lancet; 1998 Aug; 352(9125):336-7. PubMed ID: 9717914 [No Abstract] [Full Text] [Related]
5. Improving methods of screening for Down's syndrome. White I; Papiha SS; Magnay D N Engl J Med; 1989 Feb; 320(6):401-2. PubMed ID: 2464139 [No Abstract] [Full Text] [Related]
6. [Prenatal screening for Down's syndrome]. Qin Q; Christiansen M; Norgaard-Pedersen B Zhonghua Fu Chan Ke Za Zhi; 1997 Nov; 32(11):694-7. PubMed ID: 9639772 [No Abstract] [Full Text] [Related]
10. Correlations between first and second trimester markers for Down's syndrome screening. Campogrande M; Viora E; Errante G; Bastonero S; Sciarrone A; Grassi Pirrone P; Perona M; Mancini G; Dall'Amico D; Pavanello E; Guaraldo V J Med Screen; 2001; 8(3):163-4. PubMed ID: 11678558 [No Abstract] [Full Text] [Related]
11. Prospective study of prenatal screening for Down's syndrome with free beta human chorionic gonadotrophin. Spencer K; Carpenter P BMJ; 1993 Sep; 307(6907):764-9. PubMed ID: 7693095 [TBL] [Abstract][Full Text] [Related]
12. Seeking other disorders within antenatal serum screening programmes for Down's syndrome. Wald NJ; Canick JA J Med Screen; 2002; 9(4):145-6. PubMed ID: 12518002 [No Abstract] [Full Text] [Related]
13. Measurement of choriogonadotropin free beta-subunit: an alternative to choriogonadotropin in screening for fetal Down's syndrome? Knight GJ; Cole LA Clin Chem; 1991 Jun; 37(6):779-82. PubMed ID: 1828723 [No Abstract] [Full Text] [Related]
14. Antenatal maternal serum screening for Down's syndrome: results of a demonstration project. Wald NJ; Kennard A; Densem JW; Cuckle HS; Chard T; Butler L BMJ; 1992 Aug; 305(6850):391-4. PubMed ID: 1382768 [TBL] [Abstract][Full Text] [Related]
15. Second trimester screening for Down's syndrome: 7 years experience. Beaman JM; Goldie DJ J Med Screen; 2001; 8(3):128-31. PubMed ID: 11678551 [TBL] [Abstract][Full Text] [Related]
17. [The prenatal diagnosis of Down's syndrome based on the biochemical screening of maternal serum markers]. Arbuzova SB; Nikolenko MI; Khlevnaia LA; Fedotova OO; Solov'eva VD; Malova SA Tsitol Genet; 1998; 32(1):66-71. PubMed ID: 9695254 [TBL] [Abstract][Full Text] [Related]
18. Choice of serum markers in antenatal screening for Down's syndrome. Wald NJ; Watt HC J Med Screen; 1994 Apr; 1(2):117-20. PubMed ID: 8790499 [No Abstract] [Full Text] [Related]
19. Reducing the need for amniocentesis in women 35 years of age or older with serum markers for screening. Haddow JE; Palomaki GE; Knight GJ; Cunningham GC; Lustig LS; Boyd PA N Engl J Med; 1994 Apr; 330(16):1114-8. PubMed ID: 7510852 [TBL] [Abstract][Full Text] [Related]
20. Dimeric inhibin A as a marker for Down's syndrome in early pregnancy. Aitken DA; Wallace EM; Crossley JA; Swanston IA; van Pareren Y; van Maarle M; Groome NP; Macri JN; Connor JM N Engl J Med; 1996 May; 334(19):1231-6. PubMed ID: 8606718 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]